An Observational Study to Compare cardiovascular related hospitalization in chemo-naïve Patients with Metastatic Castration Resistant Prostate Cancer, treated with Enzalutamide or Abiraterone in daily practice in Germany (AVENGER)

11/05/2023
29/07/2024
EU PAS number:
EUPAS104771
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

9785-ma-3497 - original protocol-disclosure-redacted (1).pdf

English (1.72 MB - PDF) View document
Updated protocol

9785-ma-3497-protocol-v2-incorp-nonsubst-amend-01-disclosure-redacted.pdf

First published: 12/07/2024
English (1.62 MB - PDF) View document
Study results
Study report
Other information